Pharmafile Logo
Pharmafocus logo
Advanced Search
boots

Boots under fire from Labour MPs over broken contraceptive promise

November 17, 2017
Medical Communications, Sales and Marketing Boots, biotech, drugs, morning after pill, pharma, pharmaceutical

Boots, a UK high-street pharmacy, has come under pressure from Labour MPs after it failed to adhere to its own …

News
alex_azar

Trump nominates Ex-Lilly exec for health secretary role

November 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services (HHS) agency, …

Appointment
stem-cell-163711_640

Stem cell therapy fails to improve symptoms of peripheral artery disease

November 16, 2017
Research and Development Stem cells, peripheral artery disease, pharma, stem cell therapy, trial failure

A new study has revealed that a promising stem cell therapy failed to improve ability to walk in patients with …

News
nss-2_device

FDA approves electronic nerve stimulator for opioid withdrawal

November 16, 2017
Sales and Marketing NNS-2 Bridge, biotech, drugs, opioid, pharma, pharmaceutical

A device that delivers electronic pulses to the area around the ear, designed to stimulate the brain in order to …

News

GSK gets EU go-ahead for triple therapy inhaler in COPD

November 16, 2017
Sales and Marketing COPD, FDA, GSK, Trelegy Ellipta, pharma

The EMA has awarded EU marketing authorisation to GlaxoSmithKline and Innovia’s single inhaler triple therapy Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for …

News

NICE approves Novartis and Pfizer’s rival breast cancer drugs

November 16, 2017
Sales and Marketing Kisqali, Novartis, Pfizer, biotech, drugs, ibrance, pharma, pharmaceutical

NICE has announced that it has given the nod to two new treatments for breast cancer with the approval of …

News
arvinas-0004168-2

Genentech cements relationship with Arvinas with $650m deal

November 16, 2017
Research and Development, Sales and Marketing Arvinas, Genentech, Roche, biotech, drugs, pharma, pharmaceutical

Genentech first signed a deal with Arvinas, a biotech focused on drugs within the protein degradation class, back in 2015. …

News
dia

Navigating the new Clinical Trial Regulation with DIA

November 16, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …

Feature
albert-bourla_300x170px

Pfizer promotes Albert Bourla to newly-created COO role

November 15, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

In a sizeable shake-up of its business operations, Pfizer has promoted Albert Bourla (pictured) to the role of Chief Operating …

Appointment
smart_watch

NHS backs innovative means of cutting diabetes risk

November 15, 2017
Medical Communications, Research and Development NHS, biotech, drugs, pharma, pharmaceutical

It was World Diabetes Day yesterday and the NHS announced a new tech initiative to help those most at risk …

News
autolus_-_martin-pule

Promising new CAR-T therapy able to target T-cell lymphoma

November 15, 2017
Research and Development Autolus, CAR T, CAR-T, biotech, drugs, pharma, pharmaceutical

The CAR-T space has progressed rapidly over the last few years, culminating in FDA approvals for Novartis and Gilead to …

News

Psoriasis patients at greater risk of type 2 diabetes, study reveals

November 15, 2017
Research and Development diabetes, pharma, psoriasis, type 2 diabetes

Researchers at the University of Pennsylvania’s Perelman School of Medicine have discovered that people with psoriasis are more at risk …

News
kratom_leaf

FDA signals crackdown on controversial painkiller

November 15, 2017
Medical Communications, Research and Development biotech, drugs, kratom, pharma, pharmaceutical

Scott Gottlieb, the FDA’s Commissioner, issued an advisory about the medicinal plant-product known as kratom. The plant is known to …

News
astrazeneca_building_white

AstraZeneca’s Fasenra scores US approval in severe asthma

November 15, 2017
Research and Development, Sales and Marketing AstraZeneca, Fasenra, MedImmune, asthma

AstraZeneca and MedImmune, the company’s biologics research and development division, have revealed the decision by the FDA to approve Fasenra …

News

WestRock’s Multi Packaging Solutions partners with Smartglyph for SmarterBarcodes

November 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Multi Packaging Solutions

Multi Packaging Solutions, (MPS), a business of WestRock Company and a leader in value-added print and packaging solutions for the …

News
Press release
dia

Navigating the new Clinical Trial Regulation with DIA

November 14, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, dia, drugs, pharma, pharmaceutical

For those stakeholders involved with clinical trials in Europe, the new Clinical Trial Regulation to be introduced in 2019 will …

News
bi_german_building_at_night

Boehringer celebrates EU approval of Humira biosimilar

November 14, 2017
Manufacturing and Production, Sales and Marketing Boehringer, Boehringer Ingelheim, Cyltezo, EU, Europe, European Commission, Humira, biosimilar

Boehringer Ingelheim has announced that Cyltezo, its biosimilar of Abbvie’s Humira, has received marketing authorisation approval from the European Commission, …

News
novartis_side_building

Novartis targets specific patient population with strong Ilaris Phase 3 data

November 14, 2017
Manufacturing and Production, Research and Development Ilaris, Novartis, cardiovascular, heart attack, heart disease, pharma

Novartis has presented new Phase 3 data on its cardiovascular drug Ilaris (canakinumab) which demonstrate particular efficacy in a specific …

News
albert-bourla_300x170px

Pfizer creates COO role so CEO Ian Read can focus on deal-making

November 14, 2017
Manufacturing and Production, Sales and Marketing Image Credit: Pfizer

In a sizeable shake-up of its business operations, Pfizer has promoted Albert Bourla (pictured) to the role of Chief Operating …

News
online_version

Ex-Lilly exec Trump’s nominee for health secretary

November 14, 2017
Manufacturing and Production, Medical Communications Alex Azar, Donald Trump, biotech, drugs, pharma, pharmaceutical

Alex Azar is officially President Trump’s nominee for the position as head of the Health and Human Services (HHS) agency, …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026